France· FR:66097007
OPATANOL 1 mg/ml, collyre en solution
A medicinal product containing chlorhydrate d'olopatadine, registered in France by NOVARTIS EUROPHARM (IRLANDE), on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- CHLORHYDRATE D'OLOPATADINE
- Manufacturer
- NOVARTIS EUROPHARM (IRLANDE)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip1334009359897271 flacon(s) compte-gouttes polyéthylène basse densité (PEBD) de 5 mlEUR 5.63
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Chlorhydrate d'olopatadine in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesCVS Eye Allergy Itch ReliefCVS Health Corp
- SwedenOlopatadin Evolan 1 mg/ml Ögondroppar, lösningEvolan Pharma AB
- CzechiaOLOPATADINE OLIKLAOlikla s.r.o., Kostelec nad Černými Lesy
- PolandOftahistAdamed Pharma S.A.
- NetherlandsOlopatadine Brown & Burk 1 mg/ml oogdruppels, oplossingBrown & Burk IR Limited
- NorwayOpatanolNovartis Europharm Limited (1)
- IrelandOlopatadine Brown & Burk 1 mg/mL eye drops, solutionBrown & Burk IR Limited
- BelgiumOpatanol 1 mg/mlNovartis Europharm
Authorised across Europe · EMA
The same active substance is authorised in 27 EEA countries. Names it is sold under:
- Austria · Olopatadin Micro Labs, Olopatadin Unimed Pharma
- Bulgaria · Оловижън, Олопатадин Унимед Фарма
- Cyprus · Alopatan, Olopatadine Rafarm
- Czechia · Olopatadine Unimed Pharma, Olopatidine Olikla
- Germany · Alltrevo, Olopatadin Actrevo
- Denmark · Olopatadin Brown & Burk, Olopatadin Juta
- Estonia · Olopatadine Unimed Pharma
- Spain · Apadin, Olopatadina Abamed
- United Kingdom (Northern Ireland) · Olopatadine Blumont Pharma, Olopatadine Brown & Burk Uk
- Greece · Alopatan, Olopatadine Rafarm
- Croatia · Olopatadin
- Hungary · Olopatadine Unimed Pharma
- Ireland · Olopatadine Brown & Burk
- Iceland · Opatanol
- Italy · Calmira®, Olonet
- Liechtenstein · Opatanol
- Lithuania · Olopatadine Unimed Pharma
- Latvia · Olopatadine Unimed Pharma
- Malta · Olopatadine Unimed Pharma
- Netherlands · Olopatadine Brown & Burk, Optamont
- Norway · Olopatadine Sandoz, Opatanol
- Poland · Oftahist, Olodon Free
- Portugal · Olopatadina Stallpharma
- Romania · Olopatadina Brown & Burk, Olopatadină Rompharm
- Sweden · Olopatadin Evolan, Olopatadin Orifarm
- Slovenia · Olopatadin Unimed Pharma
- Slovakia · Olopatadine Olikla, Olopatadine Unimed Pharma
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ed7b7f39-67c2-4fa5-be22-f639648098fb GET /v1/drugs/ed7b7f39-67c2-4fa5-be22-f639648098fb?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "66097007",
"date_amm": "2002-05-17",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/02/217",
"substance": "CHLORHYDRATE D'OLOPATADINE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "collyre en solution",
"voies_administration": "ophtalmique",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about chlorhydrate d'olopatadine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.